Navigation Links
Roundtable of Industry Experts to Discuss Impact, Implications of EVMPD Mandate
Date:1/23/2012

CAMBRIDGE, Mass., Jan. 23, 2012 /PRNewswire/ -- Virtify, Inc., will host an online roundtable on January 25, 10 AM EST to facilitate an open discussion by senior executives from four multinational pharmaceutical companies on the specific challenges and steps they are taking to comply with the July 2, 2012 EVMPD reporting mandate.  A Q & A session will follow.

(Logo: http://photos.prnewswire.com/prnh/20110131/NE38689LOGO)

Roundtable panelists will include John W Kiser, of Abbott Laboratories USA, Dr Jorg Lautz, of Grunenthal GmbH, Germany, Gordon Topping from the Takeda Global R&D Centre (Europe), UK, and Richard Eddershaw of GSK R&D, UK.  Dr. Andrew Marr, Managing Director of Marr Consultancy will moderate the discussion.

"This roundtable will provide an excellent opportunity for the industry to share lessons learned, discuss approaches to address the unknowns which still exist, and exchange other information for addressing this challenging new requirement in a tight timeframe," said Satish Tadikonda, CEO and founder of Virtify. "In our conversations with many different drug sponsors that are working to respond to this mandate, we realized that it really makes sense to facilitate this kind of productive exchange."

Attendees can sign up to listen in to the roundtable discussion and submit questions to the panel by registering at http://www.virtify.com/news-events/events/

About Virtify

Virtify is the market leader in Structured Content Management software solutions for life sciences. Organizations rely on Virtify solutions to reduce time-to-market, risk, and costs by managing and automating the complex regulatory compliance and content exchange requirements throughout the product life cycle. Virtify's easy-to-use software suite is the industry's only solution to provide a secure, collaborative, web-based environment for managing regulated content throughout the entire continuum – from pre-clinical through product registration to commercialization. 

The company's EVMPD software enables organizations to address the EU's July 2012 submission deadline for additional EVMPD data and is part of its suite of structured content management based solutions.  The software helps customers collect, validate, and manage the relevant data and provides the capability to submit the data electronically to the EMA including the ability to efficiently provide updates on product data when product information is changed. By applying the Virtify structured content approach, all data gathered is optimized for re-use across the organization.  www.virtify.com


'/>"/>
SOURCE Virtify, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Prostate Cancer Roundtable Expresses Concern over Federal Recommendations Impeding Access to the PSA, a Key Cancer Screening Test
2. Caliper Life Sciences to Present at the Leerink Swann Life Science Tools & Diagnostics Roundtable
3. Pharmasset to Present at the Leerink Swann Hot Topics Roundtable Conference
4. Amarin to Present at the Leerink Swann Hot Topics in Therapeutics Roundtable Conference
5. RoundTable Healthcare Partners Announces Sale of Clinical Innovations, LLC to The Pritzker Group
6. RoundTable Healthcare Partners Acquires Majority Stake in Salter Labs
7. Arcadian Healths Chief Information Officer to Address Role of CIOs from a Healthcare Perspective at the CIO Executive Leadership Roundtable in Santa Monica
8. RoundTable Healthcare Partners Portfolio Company, Argon Medical Devices, Inc., Acquires Critical Care and Extended Dwell Catheter Product Platforms From BD
9. RoundTable Healthcare Partners Portfolio Company, Aspen Surgical Products, Inc., Acquires Bard-Parkerâ„¢ Surgical Blades and Scalpels Business
10. RoundTable Healthcare Partners Closes Two Funds
11. RoundTable Healthcare Partners Announces Sale of Bioniche Pharma Holdings Limited to Mylan Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... Mylan N.V. (NASDAQ, TASE: MYL) today announced ... December 31, 2015. --> --> ... revenues of $9.45 billion, up 28% on a constant ... of $9.43 billion. Excluding the impact of the acquisition ... generics business (the "EPD Business"), full year adjusted total ...
(Date:2/10/2016)... , Feb. 10, 2016  Resolve Therapeutics, LLC, ... new approaches to the treatment of lupus and ... a multiple ascending dose study in patients with ... RSLV-132. --> --> ... multiple ascending dose study of RSLV-132 in 32 ...
(Date:2/10/2016)... , Feb. 10, 2016  Rich Pharmaceuticals, Inc. (OTC ... a 1-for-100 reverse split of its issued and outstanding ... trading on Thursday, February 11, 2016. The Company,s common ... CUSIP number 76303T308 and temporary ticker symbol "RCHAD". After ... under the ticker symbol (RCHA).  --> ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... February 10, 2016 , ... Western University ... health services to the developmentally disabled in the Coachella Valley. , The two ... new facility at 71-949 Highway 111, Suite 100-B, in Rancho Mirage, California. The ...
(Date:2/10/2016)... ... February 10, 2016 , ... As part of its ongoing ... February 2016. Each webinar features a dynamic expert and thoughtful presentation to give ... patients and facilities. Both events are free to attend, but registration is ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... ... American Academy of Emergency Medicine , an emergency medicine professional association, ... practice management services . , The American Academy of Emergency Medicine, or AAEM, ...
(Date:2/10/2016)... ... 2016 , ... The Wickman Agency in Garland, TX has ... community. Pledging to select a new beneficiary every 60 days, the agency will ... is to bring community awareness to important local causes by forming campaigns which ...
(Date:2/10/2016)... ... February 10, 2016 , ... 10 Best Water ... were three leading bottled water brand owners that topped the list as a result ... and optimize conversion. The premier brand was Tibet 5100, a top notch water company ...
Breaking Medicine News(10 mins):